Symposium ON NUTRITION, METABOLISM AND CARDIOMETABOLIC PREVENTION: OMICS, epigenetics and system epidemiology. REG I N D 9.00 Introduction LIN E 09 Chair: J. Alfredo Martínez ‐ University of Navarra, Pamplona, Spain AD E 00h Speakers: th 9.00 Dolores Corella ‐ University of Valencia, Spain H 27 C R MA OMICS, nutrition and cardiometabolic prevention 10 9.20 Clary Clish ‐ Broad Institute, MIT‐Harvard University, Cambridge,USA 40h Metabolomics and application to study human cohorts 9.40 Liming Liang ‐ Harvard TH Chan School of Public Health, Boston, USA Statistical approaches to the analyses of multidimensional data including OMICS and epigenetic data 10.00 Frank B. Hu - Harvard TH Chan School of Public Health, Boston, USA Update in nutritional epidemiology of cardiovascular disease and diabetes, integration with metabolomics MAY MONDAY 18 Salón de Actos Edificio de ciencias UNIVERSIDAD DE NAVARRA Third session 13 15h 14 3 0h 11 00 h 12 30 h Second session First session RATIO ST 10.40 Coffee Break 11.00 “In memoriam” Dimitrios Trichopoulos Miguel A. Martínez‐González ‐ University of Navarra, Pamplona, Spain Valentinni Konstantinidou - Gendiag exe S.Ll, Barcelona, Spain 11.30 On-going studies on cardiovascular disease, integration with metabolomics Chair: Frank B. Hu Speakers: 11.30 Antonia Trichopoulou ‐ Hellenic Health Foundation, Athens, Greece Mediterranean diet and the health of the elderly 11.50 Miguel A. Martínez‐González Brief overview of the main results of the PREDIMED trial 12.00 Adela Hruby ‐ Harvard T.H. Chan School of Public Health, Boston, USA Nutrition and metabolomics: a systematic review 12.10 Miguel Ruiz‐Canela ‐ University of Navarra, Pamplona, Spain Metabolomics and risk of CVD: systematic review 12.20 Estefania Toledo ‐ University of Navarra, Pamplona, Spain A pilot study of metabolomics in the PREDIMED‐NAVARRA trial 12.30 Lunch break 13.15 Type-2 diabetes, diabesity and novel cardiometabolic risk factors Chair: Jordi Salas‐Salvadó ‐ University Rovira i Virgili, Reus, Spain Speakers: 13.15 Marta Guasch ‐ University Rovira i Virgili, Reus, Spain A systematic review of metabolomics and the risk of type2‐diabetes 13.30 Christian Carpene ‐ Inst. M. Métaboliques/Cardiovasculaires‐INSERM, Tolouse, France Effects of resveratrol and piceatannol in animal models of diabesity 13.50 Chih-Hao Lee ‐ Harvard T.H. Chan School of Public Health, Boston, USA Identification of novel lipid mediators in energy metabolism through lipidomics and mouse genetic models 14.10 Olle Melander ‐ Lund University, Malmö, Sweden Novel cardiometabolic risk factors‐ where genes meet diet